Walleye Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.59M | Buy |
34,295
+27,889
| +435% | +$1.29M | 0.01% | 696 |
|
|
2025
Q1 | $391K | Sell |
6,406
-95,677
| -94% | -$5.84M | ﹤0.01% | 1166 |
|
|
2024
Q4 | $5.77M | Buy |
102,083
+97,988
| +2,393% | +$5.54M | 0.01% | 395 |
|
|
2024
Q3 | $212K | Sell |
4,095
-178,207
| -98% | -$9.22M | ﹤0.01% | 1678 |
|
|
2024
Q2 | $7.57M | Buy |
+182,302
| New | +$7.57M | 0.01% | 356 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 2661 |
|
|
2023
Q4 | – | Sell |
-223,808
| Closed | -$13M | – | 2237 |
|
|
2023
Q3 | $13M | Buy |
+223,808
| New | +$13M | 0.03% | 146 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 2146 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 2174 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 2167 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2302 |
|
|
2022
Q2 | – | Sell |
-18,007
| Closed | -$1.32M | – | 2322 |
|
|
2022
Q1 | $1.32M | Sell |
18,007
-36,897
| -67% | -$2.69M | 0.04% | 486 |
|
|
2021
Q4 | $3.42M | Buy |
+54,904
| New | +$3.42M | 0.11% | 198 |
|
|
2020
Q4 | – | Sell |
-15,809
| Closed | -$953K | – | 936 |
|
|
2020
Q3 | $953K | Buy |
15,809
+8,241
| +109% | +$497K | 0.11% | 240 |
|
|
2020
Q2 | $445K | Buy |
+7,568
| New | +$445K | 0.1% | 247 |
|
|
2020
Q1 | – | Sell |
-4,170
| Closed | -$268K | – | 560 |
|
|
2019
Q4 | $268K | Buy |
4,170
+2,970
| +248% | +$191K | 0.02% | 306 |
|
|
2019
Q3 | $61K | Buy |
1,200
+600
| +100% | +$30.5K | ﹤0.01% | 336 |
|
|
2019
Q2 | $27K | Hold |
600
| – | – | ﹤0.01% | 370 |
|
|
2019
Q1 | $29K | Buy |
+600
| New | +$29K | ﹤0.01% | 270 |
|